Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Toxicol In Vitro ; 28(3): 457-67, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24368203

ABSTRACT

The inflammatory responses after exposure to zinc oxide nanoparticles (ZNPs) are known, however, the molecular mechanisms and direct consequences of particle uptake are still unclear. Dose and time-dependent increase in the uptake of ZNPs by macrophages has been observed by flow cytometry. Macrophages treated with ZNPs showed a significantly enhanced phagocytic activity. Inhibition of different internalization receptors caused a reduction in uptake of ZNPs in macrophages. The strongest inhibition in internalization was observed by blocking clathrin, caveolae and scavenger receptor mediated endocytic pathways. However, FcR and complement receptor-mediated phagocytic pathways also contributed significantly to control. Further, exposure of primary macrophages to ZNPs (2.5 µg/ml) caused (i) significant enhancement of Ras, PI3K, (ii) enhanced phosphorylation and subsequent activation of its downstream signaling pathways via ERK1/2, p38 and JNK MAPKs (iii) overexpression of c-Jun, c-Fos and NF-κB. Our results demonstrate that ZNPs induce the generation of reactive nitrogen species and overexpression of Cox-2, iNOS, pro-inflammatory cytokines (IL-6, IFN-γ, TNF-α, IL-17 and regulatory cytokine IL-10) and MAPKs which were found to be inhibited after blocking internalization of ZNPs through caveolae receptor pathway. These results indicate that ZNPs are internalized through caveolae pathway and the inflammatory responses involve PI3K mediated MAPKs signaling cascade.


Subject(s)
Inflammation/chemically induced , Macrophages/drug effects , Nanoparticles , Zinc Oxide/toxicity , Animals , Caveolae/metabolism , Cytokines/metabolism , Dose-Response Relationship, Drug , Female , Inflammation/pathology , Macrophages/pathology , Mice , Mice, Inbred BALB C , Mitogen-Activated Protein Kinases/metabolism , Phagocytosis/drug effects , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation/drug effects , Signal Transduction/drug effects , Time Factors , Zinc Oxide/administration & dosage , Zinc Oxide/metabolism
2.
Toxicol Lett ; 208(3): 239-45, 2012 Feb 05.
Article in English | MEDLINE | ID: mdl-22138556

ABSTRACT

Orange II, an azo dye, is not permitted in food preparations, but high levels of the dye have been detected in different food commodities. Though there are reports on the toxicity of Orange II but knowledge based on the immunomodulatory properties of Orange II is scanty. The present investigation was undertaken to study the in vitro immunotoxic potential of Orange II in splenocytes. Splenocytes were isolated, cultured and subjected to immunophenotypic analysis, mixed lymphocyte reaction (MLR) assay or stimulated with lipopolysaccharide (LPS) or concanavalin A (Con A) for 72 h. The supernatant was collected for cytokine assays. Orange II showed cytotoxic effects at 100-1000µg/ml concentrations and 50µg/ml was determined as the highest non-cytotoxic dose. Orange II at the non-cytotoxic dose (50µg/ml) significantly altered the relative distribution of T and B-cells, MLR response and the mitogen induced proliferative response of T-cells and B-cells. Consistent with the hypo-responsiveness of the T and B-lymphocytes, Orange II induced a concomitant decline in the secretion of cytokines IL-2, IL-4, IL-6, IFN-γ, TNF-α and IL-17. On the contrary, there was an increase in the production of IL-10, an anti-inflammatory regulatory cytokine, which may be one of the causative factor for immunosuppressive property of Orange II. These results suggest that non-cytotoxic dose of Orange II may have immunomodulatory effects.


Subject(s)
Azo Compounds/toxicity , Benzenesulfonates/toxicity , Spleen/drug effects , Spleen/immunology , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , Adaptive Immunity/drug effects , Animals , Azo Compounds/immunology , Benzenesulfonates/immunology , Cell Survival/drug effects , Coloring Agents/toxicity , Cytokines/analysis , Female , Flow Cytometry , Immunity, Innate/drug effects , Immunophenotyping/methods , Lymphocyte Culture Test, Mixed , Mice , Mice, Inbred BALB C , Spleen/cytology , T-Lymphocytes/cytology
3.
J Pharm Bioallied Sci ; 2(4): 300-6, 2010 Oct.
Article in English | MEDLINE | ID: mdl-21180461

ABSTRACT

NeuroAIDS is becoming a major health problem among AIDS patients and long-term HIV survivors. As per 2009 estimates of UNAIDS report, more than 34 million people have been infected with HIV out of which ≥ 50% show signs and symptoms of neuropsychiatric disorders. These disorders affect central nervous system (CNS) and peripheral nervous systems (PNS). CNS is one of the most protected organ systems in body which is protected by blood-brain barrier (BBB). Not only this, most of the cells of CNS are negative for receptors and co-receptors for HIV infections. Neurons have been found to be completely nonpermissive for HIV infection. These facts suggest that neurotoxicity could be an indirect mechanism responsible for neuropsychiatric complications. In this review, we will discuss the importance of different cell types of CNS and their contribution toward neurotoxicity.

SELECTION OF CITATIONS
SEARCH DETAIL
...